These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25108075)

  • 1. Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients.
    Kalousová M; Zima T; Krane V; März W; Wanner C; Tesař V; Drechsler C;
    Atherosclerosis; 2014 Oct; 236(2):263-9. PubMed ID: 25108075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
    Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
    Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.
    März W; Genser B; Drechsler C; Krane V; Grammer TB; Ritz E; Stojakovic T; Scharnagl H; Winkler K; Holme I; Holdaas H; Wanner C;
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1316-25. PubMed ID: 21493741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.
    Fenske W; Wanner C; Allolio B; Drechsler C; Blouin K; Lilienthal J; Krane V;
    J Am Soc Nephrol; 2011 Apr; 22(4):782-90. PubMed ID: 21415158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis.
    Krane V; Heinrich F; Meesmann M; Olschewski M; Lilienthal J; Angermann C; Störk S; Bauersachs J; Wanner C; Frantz S;
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):394-400. PubMed ID: 19158371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
    Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):224-31. PubMed ID: 25424990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.
    Krane V; Berger M; Lilienthal J; Winkler K; Schambeck C; Wanner C;
    Clin J Am Soc Nephrol; 2010 May; 5(5):874-81. PubMed ID: 20185595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.
    Drechsler C; Kalim S; Wenger JB; Suntharalingam P; Hod T; Thadhani RI; Karumanchi SA; Wanner C; Berg AH
    Kidney Int; 2015 Jun; 87(6):1201-8. PubMed ID: 25671766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
    Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D study.
    Hoffmann MM; März W; Genser B; Drechsler C; Wanner C
    Atherosclerosis; 2011 Dec; 219(2):659-62. PubMed ID: 21871624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients.
    Espe KM; Raila J; Henze A; Blouin K; Schneider A; Schmiedeke D; Krane V; Pilz S; Schweigert FJ; Hocher B; Wanner C; Drechsler C;
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):452-8. PubMed ID: 23335039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
    Shinozaki T; Matsuyama Y; Iimuro S; Umegaki H; Sakurai T; Araki A; Ohashi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
    Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
    Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.
    Pfau A; Ermer T; Coca SG; Tio MC; Genser B; Reichel M; Finkelstein FO; März W; Wanner C; Waikar SS; Eckardt KU; Aronson PS; Drechsler C; Knauf F
    J Am Soc Nephrol; 2021 Sep; 32(9):2375-2385. PubMed ID: 34281958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.
    Chan KE; Thadhani R; Lazarus JM; Hakim RM
    Clin J Am Soc Nephrol; 2010 May; 5(5):856-66. PubMed ID: 20338963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation.
    Nilsson E; Cao Y; Lindholm B; Ohyama A; Carrero JJ; Qureshi AR; Stenvinkel P
    Nephrol Dial Transplant; 2018 Jun; 33(6):971-977. PubMed ID: 28992321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.
    Winkler K; Wanner C; Drechsler C; Lilienthal J; März W; Krane V;
    Eur Heart J; 2008 Sep; 29(17):2092-9. PubMed ID: 18617483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus.
    Li WP; Neradilek MB; Gu FS; Isquith DA; Sun ZJ; Wu X; Li HW; Zhao XQ
    Cardiovasc Diabetol; 2017 Apr; 16(1):45. PubMed ID: 28381225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
    Wanner C; Krane V; März W; Olschewski M; Mann JF; Ruf G; Ritz E;
    N Engl J Med; 2005 Jul; 353(3):238-48. PubMed ID: 16034009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.